Funder: Breakthrough T1D
Due Dates (Anticipated): June 2026 (Full application deadline, projected)
Funding Amounts: Up to $200,000/year (including up to 10% indirect costs) for up to 5 years; generally not renewable after 5 years.
Summary: Supports early-career clinical researchers transitioning to independence in patient-oriented type 1 diabetes research, with mentorship and institutional backing.
Key Information: Applications focused on long-term complications are not accepted; psychosocial and behavioral health research is eligible.